首页> 美国卫生研究院文献>other >Biochemical Safety Profiles of Gadolinium-Based Extracellular Contrast Agents and Nephrogenic Systemic Fibrosis
【2h】

Biochemical Safety Profiles of Gadolinium-Based Extracellular Contrast Agents and Nephrogenic Systemic Fibrosis

机译:d基细胞外造影剂和肾源性系统性纤维化的生化安全性概况

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gadolinium (Gd)-based paramagnetic contrast agents are relatively safe when used in clinically recommended doses. However, with the rapidly expanding body of literature linking Gd-based paramagnetic contrast agents and nephrogenic systemic fibrosis (NSF), awareness of the potential side effects and adverse reactions from Gd is now an important requirement for practicing radiologists. In addition to the ongoing accumulation and analyses of clinical NSF data, it is also essential for the practicing radiologist to understand the biochemical characteristics of the extracellular Gd-chelates. The purpose of this review is to consolidate and update the available information on known side effects, adverse reactions, and toxicity of the Gd chelates, with particular emphasis on the potential mechanisms of NSF.
机译:当以临床推荐剂量使用时,基于d(Gd)的顺磁性造影剂相对安全。但是,随着将基于Gd的顺磁性造影剂与肾源性系统性纤维化(NSF)联系起来的文献迅速发展,现在认识到Gd的潜在副作用和不良反应已成为放射科医生的一项重要要求。除了不断积累和分析临床NSF数据外,对于放射科医生来说,了解细胞外Gd螯合物的生化特性也至关重要。这篇综述的目的是巩固和更新有关Gd螯合物的已知副作用,不良反应和毒性的可用信息,并特别强调NSF的潜在机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号